NewCardio, Inc. (OTCPK: NWCI)
Health Care · Health Care Technology · US
$0.00
— today · 0.0% 1Y
NewCardio, Inc. (OTCPK: NWCI) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $4.08K and employs 10 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores NewCardio, Inc. across four factors: quality 0/100, value 32/100. Its strongest factor is value.
NWCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.08K
- Revenue (TTM)
- $238.58K
- P/E
- —
- EPS
- -0.28
- Dividend yield
- —
- Beta (5Y)
- -114.43
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 40.81M
- Employees
- 10
- Next earnings
- —
About NewCardio, Inc.
NewCardio, Inc. is a company dedicated to cardiac diagnostics and related services. Its primary objective is the research, creation, and market introduction of exclusive software platform technologies. These innovations are designed for two main applications: the non-invasive diagnosis and continuous monitoring of cardiovascular diseases (CVD), and the assessment of cardiac safety for experimental drugs. The company's underlying technology analyzes the heart's electrical activity in real-time and in three dimensions, using data gathered from the body's surface via standard 12-lead electrocardiogram (ECG) electrodes. NewCardio is also actively developing several products. QTinno, for instance, is an automated solution for cardiac safety, utilizing algorithms to automatically measure, analyze, and report on collected ECGs, thereby streamlining traditional manual or semi-automated methods. Another product, CardioBip, is a mobile ECG system for remote transmission, comprising a portable recording and transmitting device along with web-based software that receives, processes, and interprets the data. Furthermore, the company is progressing with my3KG, a software application intended to provide a comprehensive method for evaluating cardiac electrical activity across both time and space. NewCardio, Inc. was founded in 2004 and is headquartered in Branchburg, New Jersey.
- ISIN
- US65106G1004
- Founded
- 2004
- Listed since
- Jan 4, 2008
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.27B | $247.90 | -1.05% |
| Pro Medicus LimitedASX: PME | $14.35B | AU$191.60 | -6.99% |
| M3, Inc.TSE: 2413 | $7.17B | ¥1,708.00 | -2.43% |
| Sectra AB (publ)OM: SECT B | $5.66B | Skr278.00 | -1.35% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.80B | $25.01 | +0.68% |
| Doximity, Inc.NYSE: DOCS | $4.51B | $25.33 | -2.35% |
| HeartFlow, Inc.NasdaqGS: HTFL | $3.66B | $49.67 | +18.04% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.